| scholarly article | Q13442814 |
| P2093 | author name string | Qinfeng Huang | |
| Junhong Li | |||
| Jinghui Zheng | |||
| Ailing Wei | |||
| P2860 | cites work | Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells. | Q55438944 |
| Disruption of Notch1 Induces Vascular Remodeling, Intussusceptive Angiogenesis, and Angiosarcomas in Livers of Mice | Q58450501 | ||
| Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication | Q58740348 | ||
| Notch receptor expression in adult human liver: a possible role in bile duct formation and hepatic neovascularization | Q77318126 | ||
| High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma | Q81351659 | ||
| Deregulated expression of Notch receptors in human hepatocellular carcinoma | Q81404608 | ||
| Livistona chinensis seeds inhibit hepatocellular carcinoma angiogenesis in vivo via suppression of the Notch pathway | Q87366214 | ||
| The down-regulation of Notch1 inhibits the invasion and migration of hepatocellular carcinoma cells by inactivating the cyclooxygenase-2/Snail/E-cadherin pathway in vitro | Q87424241 | ||
| C8orf4 negatively regulates self-renewal of liver cancer stem cells via suppression of NOTCH2 signalling | Q24337647 | ||
| Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis | Q24608039 | ||
| Cellular and molecular mechanisms of fibrosis | Q24648892 | ||
| Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? | Q27025083 | ||
| A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency | Q28203380 | ||
| Cancer stem cell niche: the place to be | Q28304007 | ||
| Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors | Q28513130 | ||
| The EGF-like proteins DLK1 and DLK2 function as inhibitory non-canonical ligands of NOTCH1 receptor that modulate each other's activities | Q28587853 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| The canonical Notch signaling pathway: unfolding the activation mechanism | Q29547725 | ||
| Distinct role of macrophages in different tumor microenvironments | Q29614304 | ||
| Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis | Q29614537 | ||
| Tumor metastasis: mechanistic insights and clinical challenges | Q29617676 | ||
| Notch signaling is essential for vascular morphogenesis in mice | Q29620377 | ||
| Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis | Q33752236 | ||
| Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. | Q33762356 | ||
| Notch signaling: the core pathway and its posttranslational regulation | Q34017623 | ||
| Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis | Q34110003 | ||
| Association of Notch1 with vasculogenic mimicry in human hepatocellular carcinoma cell lines | Q34371351 | ||
| lncAKHE enhances cell growth and migration in hepatocellular carcinoma via activation of NOTCH2 signaling. | Q55181025 | ||
| Cancer-associated fibroblasts promote stem cell-like properties of hepatocellular carcinoma cells through IL-6/STAT3/Notch signaling. | Q55333053 | ||
| Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function | Q34456711 | ||
| The significance of Notch1 compared with Notch3 in high metastasis and poor overall survival in hepatocellular carcinoma | Q34612059 | ||
| Delta-like 4 induces notch signaling in macrophages: implications for inflammation | Q34632202 | ||
| Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-β/BMP signaling | Q34986010 | ||
| The role of non-parenchymal cells in liver growth | Q35018045 | ||
| Notch signaling and inherited disease syndromes | Q35095915 | ||
| Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway. | Q35237526 | ||
| Notch3 functions as a regulator of cell self-renewal by interacting with the β-catenin pathway in hepatocellular carcinoma | Q35551840 | ||
| Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. | Q35620884 | ||
| Mature hepatocytes exhibit unexpected plasticity by direct dedifferentiation into liver progenitor cells in culture | Q35713428 | ||
| Notch signaling in ocular vasculature development and diseases | Q35719022 | ||
| Altered Notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects | Q35748038 | ||
| HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity | Q35757997 | ||
| Notch3 regulates the activation of hepatic stellate cells | Q35872127 | ||
| Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma | Q35889547 | ||
| NOTCH2 signaling confers immature morphology and aggressiveness in human hepatocellular carcinoma cells | Q36041643 | ||
| The Histone Deacetylase Inhibitor Vaproic Acid Induces Cell Growth Arrest in Hepatocellular Carcinoma Cells via Suppressing Notch Signaling | Q36048511 | ||
| Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma | Q36299435 | ||
| Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice | Q36421780 | ||
| Hepatitis B virus X protein promotes the growth of hepatocellular carcinoma by modulation of the Notch signaling pathway | Q36642168 | ||
| Cancer stem cells in the development of liver cancer | Q36793453 | ||
| Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma | Q36881080 | ||
| Epidemiology of hepatocellular carcinoma: consider the population | Q36930514 | ||
| The Notch pathway promotes the cancer stem cell characteristics of CD90+ cells in hepatocellular carcinoma | Q36962663 | ||
| Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice. | Q37136259 | ||
| Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression | Q37269259 | ||
| Molecular mechanisms of hepatocellular carcinoma | Q37323726 | ||
| Cutaneous Notch signaling in health and disease. | Q37340356 | ||
| Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics | Q37355835 | ||
| Liver stem cells and hepatocellular carcinoma | Q37358938 | ||
| Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. | Q37594746 | ||
| Canonical and non-canonical Notch ligands | Q37785194 | ||
| The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. | Q37800217 | ||
| Notch signalling in solid tumours: a little bit of everything but not all the time | Q37867484 | ||
| Possible roles of DLK1 in the Notch pathway during development and disease | Q37986963 | ||
| Hepatic stellate cells--the pericytes in the liver | Q38071948 | ||
| Review of angiogenesis in hepatocellular carcinoma | Q38188582 | ||
| Immunohistochemical localization of CD31, NOTCH1 and JAGGED1 proteins in experimentally induced polycystic ovaries of immature rats. | Q38348674 | ||
| Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53 | Q38453169 | ||
| Hepatitis B virus X protein and hypoxia‑inducible factor-1α stimulate Notch gene expression in liver cancer cells | Q38731239 | ||
| Notch2 is a crucial regulator of self-renewal and tumorigenicity in human hepatocellular carcinoma cells | Q38768645 | ||
| Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling | Q38773961 | ||
| The interplay of the Notch signaling in hepatic stellate cells and macrophages determines the fate of liver fibrogenesis. | Q38812340 | ||
| Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy. | Q38841311 | ||
| Total alkaloids of Rubus alceifolius Poir inhibit tumor angiogenesis through suppression of the Notch signaling pathway in a mouse model of hepatocellular carcinoma | Q38946298 | ||
| Downregulation of Notch1 inhibits the invasion of human hepatocellular carcinoma HepG2 and MHCC97H cells through the regulation of PTEN and FAK. | Q38967283 | ||
| Notch1 promotes hepatitis B virus X protein-induced hepatocarcinogenesis via Wnt/β-catenin pathway | Q38975804 | ||
| The 4 Notch receptors play distinct and antagonistic roles in the proliferation and hepatocytic differentiation of liver progenitors | Q39074784 | ||
| Notch1 activation contributes to tumor cell growth and proliferation in human hepatocellular carcinoma HepG2 and SMMC7721 cells | Q39291000 | ||
| Morphologic Subtypes of Hepatocellular Carcinoma | Q39307606 | ||
| Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma | Q39448366 | ||
| Valproic acid inhibits human hepatocellular cancer cells growth in vitro and in vivo | Q39519611 | ||
| Gene expression profiles during activation of cultured rat hepatic stellate cells by tumoral hepatocytes and fetal bovine serum | Q39804134 | ||
| Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism | Q39869859 | ||
| Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma. | Q39939616 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma | Q40094616 | ||
| Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma | Q40177991 | ||
| Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis | Q40191484 | ||
| Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. | Q40606801 | ||
| Jagged1 DNA Copy Number Variation Is Associated with Poor Outcome in Liver Cancer | Q40694809 | ||
| Prognostic significance of Hes-1, a downstream target of notch signaling in hepatocellular carcinoma | Q41730236 | ||
| Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells | Q42360452 | ||
| Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma | Q42652080 | ||
| RITA inhibits growth of human hepatocellular carcinoma through induction of apoptosis | Q45124974 | ||
| The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis | Q45345843 | ||
| Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. | Q46127843 | ||
| Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma | Q46810766 | ||
| Notch1 increases Snail expression under high reactive oxygen species conditions in hepatocellular carcinoma cells | Q46912092 | ||
| Promotion of colorectal cancer invasion and metastasis through activation of NOTCH-DAB1-ABL-RHOGEF protein TRIO. | Q48444479 | ||
| Lidamycin decreases CD133 expression in hepatocellular carcinoma via the Notch signaling pathway. | Q49175481 | ||
| Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. | Q51894736 | ||
| Notch signaling: numb makes the difference. | Q52734603 | ||
| Expression of Notch1, Jagged1 and beta-catenin and their clinicopathological significance in hepatocellular carcinoma. | Q53306826 | ||
| Downregulation of the Notch signaling pathway inhibits hepatocellular carcinoma cell invasion by inactivation of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor. | Q54501578 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 1570-1579 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | Journal of Cancer | Q6294901 |
| P1476 | title | The Carcinogenic Role of the Notch Signaling Pathway in the Development of Hepatocellular Carcinoma | |
| P478 | volume | 10 |
| Q98564461 | Aspartate β-hydroxylase as a target for cancer therapy |
| Q92029927 | Hsa_circ_0058124 promotes papillary thyroid cancer tumorigenesis and invasiveness through the NOTCH3/GATAD2A axis |
| Q98471403 | Liver progenitor cell-driven liver regeneration |
| Q91844086 | Protein-protein interaction modulators: advances, successes and remaining challenges |
| Q90724962 | The Roles of Notch Signaling in Liver Development and Disease |
Search more.